Tarsus Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Tarsus Pharmaceuticals, Inc. has filed 647 SEC EDGAR filings since 07 Aug 2020

SEC filing history

Showing 426-450 of 647 matching filings.

Per page
25
Current page
18
4

FORM 4

Filing date
17 Feb 2023
Reporting date
15 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91774

AMENDMENT NO. 1

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91774

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91774

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91774

TARSUS PHARMACEUTICALS, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91774

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Feb 2023
Reporting date
08 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91774

SC 13G/A filing

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91774

SC 13G filing

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91774

SC 13G filing

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91774

SC 13G

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Jan 2023
Reporting date
23 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 Jan 2023
Reporting date
06 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jan 2023
Reporting date
18 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jan 2023
Reporting date
11 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Dec 2022
Reporting date
21 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Dec 2022
Reporting date
14 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2022
Reporting date
02 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2022
Reporting date
02 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .